Galmed Medical Research

At Manningham Medical Centre, you can find all the data about Galmed Medical Research. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.

Galmed Pharmaceuticals

https://galmedpharma.com/

Galmed Pharmaceuticals Leveraging Science for Lifetime Medicine From a one-man discovery to a passionate global drug development team working on the next …

About us : Galmed Pharmaceuticals

https://galmedpharma.com/about-us/

Galmed Medical Research is founded by Tuvia Gilat and Allen Baharaff to develop Aramchol for metabolic and liver diseases. 2002. A team of scientists led by Professors Jeffrey M. …

Galmed Pharmaceuticals Ltd. | LinkedIn

https://www.linkedin.com/company/galmed-medical-research/

Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramchol™, a backbone drug candidate...

Galmed Announces Issuance of New Composition of Matter …

https://finance.yahoo.com/news/galmed-announces-issuance-composition-matter-130000697.html

TEL AVIV, Israel, Feb. 8, 2023 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical …

People : Galmed Pharmaceuticals

https://galmedpharma.com/people/

+24 years of experience in academic research & the pharmaceutical/ medical device industry. Holds a Ph.D. in Neuroscience and MBA in Health Innovation. An executive …

Galmed reports interim results from the Open-Label part of the …

https://galmedpharma.investorroom.com/2022-04-28-Galmed-reports-interim-results-from-the-Open-Label-part-of-the-ARMOR-study-with-Aramchol-showing-robust-fibrosis-improvement-across-multimodality-histological-assessment

Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Their lead …

Galmed Hosting KOL Symposium and Pipeline Update

https://galmedpharma.investorroom.com/2021-01-19-Galmed-Hosting-KOL-Symposium-and-Pipeline-Update

Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead …

News - Investors Center

https://galmedpharma.investorroom.com/2012-03-12-Phase-II-Aramchol-Clinical-Trial-Results

Galmed Medical Research, Ltd (www.galmedpharma.com) is a biopharmaceutical company that develops innovative, proprietary drugs for the treatment …

Research programme: metabolic disease therapeutics

https://adisinsight.springer.com/drugs/800029201

Galmed Medical Research is developing fatty acid bile acid conjugates (FABACs), for the treatment of lipid metabolism disorders, such as cholesterol gallstones, Research …

Galmed Pharmaceuticals (NASDAQ:GLMD) Research Coverage …

https://www.defenseworld.net/2023/02/17/galmed-pharmaceuticals-nasdaqglmd-research-coverage-started-at-stocknews-com-2.html

Galmed Pharmaceuticals Stock Down 4.5 % GLMD opened at $0.58 on Friday. Galmed Pharmaceuticals has a twelve month low of $0.29 and a twelve month …

Need more information about Galmed Medical Research?

At Manningham Medical Centre, we collected data on more than just Galmed Medical Research. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.